Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV003356323 | SCV004068917 | uncertain significance | Hereditary cancer-predisposing syndrome | 2023-06-29 | criteria provided, single submitter | clinical testing | The p.S372P variant (also known as c.1114T>C), located in coding exon 11 of the FANCC gene, results from a T to C substitution at nucleotide position 1114. The serine at codon 372 is replaced by proline, an amino acid with similar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Center for Genomic Medicine, |
RCV003989837 | SCV004806826 | likely pathogenic | Fanconi anemia complementation group C | 2024-03-26 | criteria provided, single submitter | clinical testing |